rheumatoid arthritis
FDA Warns of Possible Serious CV Events, Cancer Linked to Xeljanz
The FDA issued an alert concerning an increased risk for serious cardiovascular events and malignancies with the ...
FEBRUARY 8, 2021
Despite Improvements in RA Tx, Risk for Lymphoma Persists
Patients with rheumatoid arthritis are at increased risk for developing lymphoma, despite the use of biologic ...
JUNE 13, 2017
Load more